Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation
|ClinicalTrials.gov Identifier: NCT01609712|
Recruitment Status : Unknown
Verified June 2012 by Robert Pflugmacher, University Hospital, Bonn.
Recruitment status was: Recruiting
First Posted : June 1, 2012
Last Update Posted : June 5, 2012
Patients with vertebral fractures often have problems to straighten and as a consequence of impaired lung ventilation that leads to a impaired lung function. Furthermore, it comes to the sintering of the vertebra and a so-called hunchback. This also contributes to the poorer expansion of the lung. Pain is also caused by respiratory excursions of the chest which hinder the patients to use their entire lung volume.
Kyphoplasty is designed to counter all these consequences of vertebral fractures by bringing stability to the fracture.
In order to prove the thesis the results of lung function test (FEV1, PEF) are assessed.
|Condition or disease||Intervention/treatment|
|Osteoporotic Vertebral Compression Fractures Lung Function||Procedure: Radiofrequency Kyphoplasty|
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation|
|Study Start Date :||May 2012|
Patient with vertebral compression fracture
RF kyphoplasty is standard of care in our hospital for patients with osteoporortic compression fractures. We are intersetd, if it also can improve the lung function.
Procedure: Radiofrequency Kyphoplasty
Radiofrequency kyphoplasty is a new form of surgical treatment. It injects an ultrahigh viscosity cement into the fractured vertebral body, using radiofrequency to achieve the proper consistency of the cement. This ultrahigh viscosity cement is designed to first restore proper height and alignment to the fractured vertebra and then to stabilize the fracture, thereby preventing further intravertebral motion and reducing pain.
The RF-Kyphoplasty is standard of care in our hospital. It is FDA and CE approved.
Other Name: RF-Kyphoplasty
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01609712
|Contact: Robert Pflugmacher, M.D.||+email@example.com|
|Contact: Rahel Bornemannfirstname.lastname@example.org|
|Orthopädie und Unfallchirurgie Universitätsklinikum Bonn||Recruiting|
|Bonn, NRW, Germany, 53127|
|Contact: Robert Pflugmacher, M.D. +49-151-58233263 email@example.com|
|Principal Investigator:||Robert Pflugmacher, M.D.||Orthopädie und Unfallchirurgie, Universitätsklinkum Bonn|